# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- Reuters
Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing no...
Strategic collaboration will strengthen Spain's open and ethical AI initiatives to stimulate economic and technical efforts...
https://www.reuters.com/technology/spains-high-court-suspends-209-mln-fines-apple-amazon-amid-appeal-2024-02-08/#:~:text=MADRID...
Grifols, the Spanish multinational pharmaceutical titan involved into blood-related medicines, saw its shares fall by 24% on Tu...
https://www.defense.gov/News/Releases/Release/Article/3621110/statement-from-secretary-of-defense-lloyd-j-austin-iii-on-ensurin...
The U.S. stock market wasn’t the only one to rally in 2023, and many U.S.-based investors would have found it beneficial to div...
-Reuters Citing Draft Document
Bank of America analysts reiterated a markedly bearish stance on the fate of European equities, predicting a decline of at leas...